Solara Active Pharma Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 320.13 | 278.96 | 301.80 |
| Operating Expense | 262.12 | 230.42 | 242.62 |
| Net Profit | 10.53 | -4.88 | 8.10 |
| Net Profit Margin | 3.29 | -1.75 | 2.68 |
| Earning Per Share | 2.46 | -1.65 | 2.47 |
| EBIDTA | 58.01 | 48.54 | 59.18 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 320.13 |
| Operating Expense | 262.12 |
| Net Profit | 10.53 |
| Net Profit Margin | 3.29 |
| Earning Per Share | 2.46 |
| EBIDTA | 58.01 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,283.76 | 1,288.92 | 1,443.81 |
| Operating Expenses Annual | 1,079.92 | 1,383.98 | 1,309.77 |
| Operating Profit Annual | 212.98 | -279.33 | 156.18 |
| Interest Annual | 114.81 | 105.97 | 90.06 |
| Depreciation | 83.59 | 88.21 | 92.50 |
| Net Profit Annual | -1.08 | -566.87 | -22.21 |
| Tax Annual | TBA | 78.54 | -22.57 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,283.76 |
| Operating Expenses Annual | 1,079.92 |
| Operating Profit Annual | 212.98 |
| Interest Annual | 114.81 |
| Depreciation | 83.59 |
| Net Profit Annual | -1.08 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 8.32 | 8.55 | 46.27 |
| Cash Flow from Operations | 212.80 | 110.95 | 156.17 |
| Cash Flow from Investing | -36.83 | -4.66 | -81.13 |
| Cash Flow from Financing | -180.48 | -106.52 | -112.76 |
| Cash Flow at the End | 3.81 | 8.32 | 8.55 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 8.32 |
| Cash Flow from Operations | 212.80 |
| Cash Flow from Investing | -36.83 |
| Cash Flow from Financing | -180.48 |
| Cash Flow at the End | 3.81 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 16.59 | -6.99 | 10.82 |
| PBIT Margin (%) | 8.86 | -14.98 | 3.14 |
| PBT Margin (%) | 8.78 | -14.84 | 3.11 |
| Net PROFIT Margin (%) | -0.08 | -43.98 | -1.54 |
| Return On Networth / Equity (%) | TBA | TBA | -1.47 |
| Return On Networth /Employed (%) | TBA | TBA | 1.74 |
| Return On Assets (%) | -0.05 | -24.63 | -0.86 |
| Total Debt / Equity (X) | 0.89 | 0.83 | 0.68 |
| Asset Turnover Ratio (%) | 0.65 | 0.56 | 0.56 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 16.59 |
| PBIT Margin (%) | 8.86 |
| PBT Margin (%) | 8.78 |
| Net PROFIT Margin (%) | -0.08 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -0.05 |
| Total Debt / Equity (X) | 0.89 |
| Asset Turnover Ratio (%) | 0.65 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,184.52 | 1,258.70 | 1,333.22 |
| Total Current Assets Annual | 728.60 | 790.65 | 1,190.87 |
| Non Current Assets Annual | 1,496.50 | 1,555.95 | 1,704.08 |
| Total Shareholders Funds Annual | 1,096.21 | 937.42 | 1,503.13 |
| Total Assets Annual | 2,225.10 | 2,346.60 | 2,894.95 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,184.52 |
| Total Current Assets Annual | 728.60 |
| Non Current Assets Annual | 1,496.50 |
| Total Shareholders Funds Annual | 1,096.21 |
| Total Assets Annual | 2,225.10 |
EPS (INR)
Expected
2.37
Reported
2.46
Surprise
3.80%
Mar 2025
EPS beaten by 3.80%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 1.00%
